Clinical Trials

Showing trials with last updates posted in 2020.

NCT04262388 | WITHDRAWN | PHASE2
0 participants

A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation

Study Type:
INTERVENTIONAL
Last Updated:
2020-11-17
Start Date:
2021-01-31
Completion:
2023-01-31
Conditions
  • Pancreatic Ductal Adenocarcinoma
  • Non-small Cell Lung Cancer
  • Squamous Cell Carcinoma of Head and Neck
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page